PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Buckwheat protein shows powerful hypocholesterolemic activity in rats, stronger than soy protein, and reduces low-density lipoprotein cholesterol [PMID:25363871].
Consumption of buckwheat protein suppresses cholesterol-induced gallstones in rodents [PMID:25363871].
Reviews suggest buckwheat possesses antidiabetic, anti-inflammatory, neuroprotective, and anticancer activities [PMID:37818573, PMID:26270637, PMID:33357186].
Buckwheat is reported to provide benefits in the improvement of hypertension conditions [PMID:26270637, PMID:26948610].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 38976201 (2024) — Buckwheat Allergy in Asia. · Current allergy and asthma reports
- 2.PMID: 33916396 (2021) — Tartary Buckwheat in Human Nutrition. · Plants (Basel, Switzerland)
- 3.PMID: 37818573 (2024) — A Recent Advance on Phytochemicals, Nutraceutical and Pharmacological Activities of Buckwheat. · Combinatorial chemistry & high throughput screening
- 4.PMID: 25363871 (2015) — Hypolipidemic activity of common (Fagopyrum esculentum Moench) and tartary (Fagopyrum tataricum Gaertn.) buckwheat. · Journal of the science of food and agriculture
- 5.PMID: 32765557 (2020) — Fagopyrum esculentum ssp. ancestrale-A Hybrid Species Between Diploid F. cymosum and F. esculentum.